PURPLE BIOTECH LTD-ADR (PPBT) Stock Income Statement
NASDAQ:PPBT - Nasdaq - US74638P1093 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 23.00K | 39.00K | 97.00K | 92.00K | 84.00K | |||
| Operating Expenses | 7.81M | 10.80M | 22.27M | 22.60M | 17.92M | |||
| Research and Development | 4.96M | 7.62M | 17.03M | 16.32M | 11.83M | |||
| Selling, General, and Administrative Expenses | 2.85M | 3.00M | 5.04M | 6.08M | 5.86M | |||
| Operating Income | -7.81M | -10.80M | -22.27M | -22.60M | -17.92M | |||
| Interest Income/Expense | 4.06M | 4.13M | 4.42M | 843.00K | 108.00K | |||
| Other Income/Expense | N/A | -406.00K | -2.13M | N/A | N/A | |||
| Non Recurring Items | N/A | -202.00K | N/A | N/A | -12.00K | |||
| Income Before Taxes | -3.95M | -7.28M | -19.98M | -21.76M | -17.83M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Net Income | -3.93M | -7.24M | -19.88M | -21.67M | -18.38M | |||
| EBITDA | -7.63M | -10.62M | -22.07M | -22.40M | -17.69M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.17 | -3.98 | -15.90 | -23.86 | -19.88 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD